Global Strategic Fund I Venbio's Net Worth
Global Strategic Fund I Venbio's net worth is estimated to be at least $28,097,369.87 as of 11/20/2024. CoreStreet's estimation of Global Strategic Fund I Venbio's net worth is based on their sale of stock and current holding of stock.
Global Strategic Fund I Venbio is Major Shareholder at Artiva Biotherapeutics, Inc. Common Stock. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 416,666 units of ARTV stock on 07/22/2024. Their biggest sale was on 04/19/2022 when they sold 399,923 units of Checkmate Pharmaceuticals Inc stock for $4,167,197.66. They typically trade 3 times per year.
Total value of insider buys:
- $10,785,202.00
Total value of insider sells:
- $17,312,167.87
Most recent insider trade:
- July 22, 2024
Global Strategic Fund I Venbio's Insider Trading History
| Artiva Biotherapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 22, 2024 | Major Shareholder | 416,666 | $12.00 | Buy | $4,999,992.00 |
| Elevation Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 25, 2022 | Major Shareholder | 702,737 | $4.12 | Sell | $2,895,276.44 |
| Checkmate Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 16, 2022 | Major Shareholder | 95,800 | $10.45 | Sell | $1,001,110.00 |
May 13, 2022 | Major Shareholder | 35,850 | $10.45 | Sell | $374,632.50 |
May 11, 2022 | Major Shareholder | 17,700 | $10.38 | Sell | $183,726.00 |
May 9, 2022 | Major Shareholder | 17,600 | $10.37 | Sell | $182,512.00 |
May 6, 2022 | Major Shareholder | 48,334 | $10.37 | Sell | $501,223.58 |
May 4, 2022 | Major Shareholder | 37,500 | $10.37 | Sell | $388,875.00 |
May 2, 2022 | Major Shareholder | 153,700 | $10.38 | Sell | $1,595,406.00 |
April 29, 2022 | Major Shareholder | 69,230 | $10.38 | Sell | $718,607.40 |
April 27, 2022 | Major Shareholder | 47,396 | $10.38 | Sell | $491,970.48 |
April 25, 2022 | Major Shareholder | 27,668 | $10.39 | Sell | $287,470.52 |
April 21, 2022 | Major Shareholder | 62,200 | $10.38 | Sell | $645,636.00 |
April 19, 2022 | Major Shareholder | 399,923 | $10.42 | Sell | $4,167,197.66 |
| Akero Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 6, 2020 | Major Shareholder | 4,603 | $33.83 | Sell | $155,719.49 |
July 1, 2020 | Major Shareholder | 108,064 | $34.45 | Sell | $3,722,804.80 |
June 24, 2019 | Major Shareholder | 250,000 | $16.00 | Buy | $4,000,000.00 |
| Apellis Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 13, 2017 | Major Shareholder | 127,515 | $14.00 | Buy | $1,785,210.00 |